Automation from GNF Systems Opens New Therapeutic Opportunities
6 Feb 2014
GNF scientists introduce a new high throughput screening system that enables fully automated, high throughput flow cytometry. This new system will enable screening of more complex, disease relevant assays while decreasing the time from screen to lead identification. This effort has facilitated our ability to run phenotypic screens across multiple disease areas, enabling discovery of novel drugs.
About the company

GNF Systems
GNF Systems is a leading innovator and manufacturer of advanced laboratory automation systems for genomics, biological and drug discovery. GNF Systems is best known for its high throughput screening systems that offer unsurpassed screening capacity, rates, accuracy, flexibility and most of all, reliability. The company also manufactures systems for genome scale cell-based assessment of gene function, automated protein production, purification and crystallography and, now, high throughput automated tissue culture and cell-based compound profiling.
